Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery
MEIJE
1 other identifier
interventional
256
1 country
4
Brief Summary
A normative development concerning the mechanical resistance tests of the the femoral stems led to contraindicate, in September 2014, to implant Meije Duo ™ femoral stems size 1 or 2 in patients weighing more than 60 kg due to an assumed risk of femoral stem breakage. This contraindication is based on standardized mechanical tests which may have not taken into account the changes in patient weight that may occur after the intervention. To date, investigators have not been aware of any Meije Duo ™ size 1/2 brakeage in our patients implanted with this type of prosthesis regardless of their weights before 2014. However, it is possible that some of them have had a prostheses failure and consulted another hospital. In the absence of a clinical study on this problem, investigators decided to set up a health care assessment study collecting retrospective and prospective information from our patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 23, 2019
CompletedFirst Submitted
Initial submission to the registry
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 11, 2022
CompletedMarch 23, 2023
March 1, 2023
2.3 years
February 4, 2020
March 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pourcentage of participants who had stem (Meije DuoTM size 1 or 2) breakage occured between implantation and the study follow-up call phone.
The number of stem breakage that occured since prostheses implantation will be collected by asking every participant during the follow-up call phone and performing hip xray to eligible ones (see above)
Up to 4 weeks, starting from the call phone (patient consent)
Secondary Outcomes (3)
Pourcentage of participants who had other prostheses failures (loosening of the prosthesis, femoral fracture, dislocation)
Up to 4 weeks, starting from the call phone (patient consent)
The change of physical activity in participants from baseline (prostheses implantation) to study call-phone point time.
Change from baseline Devane score at postoperative 4 years
The change of the weight and the body mass index (BMI) of the patients after the implantation of Meije DuoTM rods size 1 or 2
Change from baseline weight and BMI at postoperative 4 years
Study Arms (1)
Patients implanted with Meije duo stem size 1 or 2
OTHERAmong this arm, patients that meet criteria ( weight\> 60kg and / or a long neck / varus and / or a DEVANE score ≥ 4 ) will perform hip X ray
Interventions
Radiographs of the implanted hip with Meije duo size1 or 2 are performed in eligible patients ( Weigh\>60, Long neck stem, Varus; DEVANE score ≥ 4)
Eligibility Criteria
You may qualify if:
- An x-ray of the hip concerned will be performed on all consenting patients, having at least one criterion of the following three during their medical history since the implantation of the hip prosthesis.
- Weight\> 60 kg
- DEVANE score ≥ 4
- Long neck / varus
You may not qualify if:
- The patient expresses his opposition to the use of his personal data
- Patients (\<18 years old)
- Patients unable or out of state to express their consent
- Patient unable to speak French
- Patient with memory impairment or cognitive impairment
- Patient not affiliated to a social security or equivalent health coverage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Groupe Hospitalier Diaconesses Croix saint Simon
Paris, 75020, France
Orthopedic department
Paris, 75020, France
Groupe Hospitalier Diaconesses Croix Saint Simon
Paris, Île-de-France Region, 75020, France
Groupe Hospitalier Dianconesses croix saint Simon
Paris, Île-de-France Region, 75020, France
Related Publications (3)
Wroblewski BM, Siney PD, Fleming PA. Increasing patients' body mass. Are the criteria for testing stemmed femoral components in total hip arthroplasty still valid? Proc Inst Mech Eng H. 2007 Nov;221(8):959-61. doi: 10.1243/09544119JEIM305.
PMID: 18161256BACKGROUNDSilva M, Shepherd EF, Jackson WO, Dorey FJ, Schmalzried TP. Average patient walking activity approaches 2 million cycles per year: pedometers under-record walking activity. J Arthroplasty. 2002 Sep;17(6):693-7. doi: 10.1054/arth.2002.32699.
PMID: 12216021BACKGROUNDWesterman AP, Moor AR, Stone MH, Stewart TD. Hip stem fatigue: : The implications of increasing patient mass. Proc Inst Mech Eng H. 2018 May;232(5):520-530. doi: 10.1177/0954411918767200. Epub 2018 Apr 2.
PMID: 29608134RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon MARMOR, MD
Groupe Hospitalier Diaconesses Croix Saint-Simon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- orthopedic surgeon
Study Record Dates
First Submitted
February 4, 2020
First Posted
February 10, 2020
Study Start
March 23, 2019
Primary Completion
July 12, 2021
Study Completion
April 11, 2022
Last Updated
March 23, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share